Work

MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation

Year: 2011

Type: article

Source: Investigational New Drugs

DOI: 10.1007/s10637-011-9770-x

Authors: Li Wang, Kathy A. Mason, K. Kian Ang, Thomas Buchholz, David Valdecanas, Anjili Mathur, Carolyn Buser-Doepner, Carlo Toniatti, Luka Milas

Institutions: The University of Texas MD Anderson Cancer Center, Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2050050592

FWCI: 2.593

Cites: 37

Cited by: 84

Related to: 10